Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUN.TA)
ILA 38.0
(-0.26%)
ILA 38.0
(-0.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.02 Million | -18.21 Million | -23.17 Million | -24.37 Million | -3.35 Million | -1.75 Million |
| Net Income | -94.01 Million | -49.14 Million | -34.02 Million | -34.74 Million | -10.93 Million | -21.17 Million |
| Depreciation & Amortization | 58.71 Million | 52.2 Million | 19.7 Million | 13.93 Million | 47 Thousand | - |
| Deferred income taxes | 678 Thousand | -4.24 Million | - | - | - | - |
| Stock-based compensation | 417 Thousand | 1.35 Million | 6.2 Million | 7.47 Million | 1.39 Million | - |
| Change in working capital | 25.36 Million | -10.02 Million | -6.2 Million | -12.36 Million | 5.24 Million | -222 Thousand |
| Other non-cash items | 5.82 Million | -8.35 Million | -8.85 Million | 1.31 Million | 888 Thousand | 19.63 Million |
| Investing Cash Flow | -727 Thousand | -11.12 Million | -10.16 Million | -27.14 Million | -96.41 Million | -1.75 Million |
| Investments in PPE | -1.09 Million | -11.9 Million | -10.31 Million | -26.31 Million | -12.94 Million | -1.72 Million |
| Acquisitions | - | - | - | - | -83.45 Million | - |
| Investment purchases | - | - | - | - | - | -25 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 368 Thousand | 782 Thousand | 151 Thousand | -827 Thousand | -15 Thousand | -25 Thousand |
| Financing Cash Flow | 8.63 Million | 17.68 Million | 35.71 Million | 60.65 Million | 99.13 Million | 5.23 Million |
| Debt repayment | -1.6 Million | -179 Thousand | -28 Thousand | -3.76 Million | -70 Thousand | -3.87 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 7.52 Million | 21.06 Million | 35.66 Million | 63.46 Million | 95.44 Million | 1.26 Million |
| Other Financing Activities | 10.24 Million | -3.2 Million | 84 Thousand | 950 Thousand | 3.69 Million | 3.96 Million |
| Accounts receivables | 7.06 Million | -3.19 Million | -3.75 Million | -3.96 Million | - | - |
| Accounts payables | -7.06 Million | 3.19 Million | 3.75 Million | 3.96 Million | - | - |
| Inventory | 15.59 Million | -7.74 Million | 2.16 Million | -15.73 Million | - | - |
| Other working capital | 9.77 Million | -2.28 Million | -8.36 Million | 3.37 Million | 5.24 Million | -369 Thousand |
| Cash at beginning of period | 1.75 Million | 13.41 Million | 11.03 Million | 1.9 Million | 2.53 Million | 813 Thousand |
| Cash at end of period | 6.64 Million | 1.75 Million | 13.41 Million | 11.03 Million | 1.9 Million | 2.53 Million |
| Capital Expenditure | -1.09 Million | -11.9 Million | -10.31 Million | -26.31 Million | -12.94 Million | -1.72 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 4.88 Million | -11.66 Million | 2.38 Million | 9.13 Million | -633 Thousand | 1.72 Million |
| Free Cash Flow | -4.11 Million | -30.12 Million | -33.48 Million | -50.69 Million | -16.3 Million | -3.48 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -14.34 Million | -14.34 Million | -94.01 Million | -10.68 Million | -10.68 Million | -33.76 Million |
| Depreciation & Amortization | 12.12 Million | 12.12 Million | 58.71 Million | 3.5 Million | 3.5 Million | 25.18 Million |
| Deferred income taxes | - | - | 678 Thousand | - | - | - |
| Stock-based compensation | 62.5 Thousand | 62.5 Thousand | 417 Thousand | 204.5 Thousand | 204.5 Thousand | 209.5 Thousand |
| Change in working capital | 3.08 Million | 3.08 Million | 25.36 Million | 6.47 Million | 6.47 Million | 5.59 Million |
| Other non-cash items | -1.61 Million | -1.61 Million | 5.82 Million | 3.34 Million | 3.34 Million | -1.57 Million |
| Investing Cash Flow | -40 Thousand | -40 Thousand | -727 Thousand | 62.5 Thousand | 62.5 Thousand | -426 Thousand |
| Investments in PPE | -40 Thousand | -40 Thousand | -1.09 Million | 1500.00 | 1500.00 | -549 Thousand |
| Acquisitions | - | - | - | - | - | 246 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 368 Thousand | 61 Thousand | 61 Thousand | 123 Thousand |
| Financing Cash Flow | -500.49 Thousand | -500.49 Thousand | 8.63 Million | -2.13 Million | -2.13 Million | 6.45 Million |
| Debt repayment | - | - | -1.6 Million | - | - | -7.2 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -500.00 | -500.00 | - |
| Common Stock Issuance | - | - | 7.52 Million | - | - | 7.52 Million |
| Other Financing Activities | -500.49 Thousand | -500.49 Thousand | 10.24 Million | -2.13 Million | -2.13 Million | 6.45 Million |
| Accounts receivables | -670.5 Thousand | -670.5 Thousand | 7.06 Million | 2.23 Million | 2.23 Million | 1.29 Million |
| Accounts payables | - | - | -7.06 Million | - | - | 901 Thousand |
| Inventory | 3.4 Million | 3.4 Million | 15.59 Million | 4.49 Million | 4.49 Million | 3.3 Million |
| Other working capital | 348.5 Thousand | 348.5 Thousand | 9.77 Million | -261 Thousand | -261 Thousand | 997.5 Thousand |
| Cash at beginning of period | - | - | 1.75 Million | - | - | 2.15 Million |
| Cash at end of period | -1.23 Million | -1.23 Million | 6.64 Million | 763.5 Thousand | 763.5 Thousand | 5.52 Million |
| Capital Expenditure | -40 Thousand | -40 Thousand | -1.09 Million | 1500.00 | 1500.00 | -549 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.23 Million | -1.23 Million | 4.88 Million | 763.5 Thousand | 763.5 Thousand | 3.36 Million |
| Free Cash Flow | -733 Thousand | -733 Thousand | -4.11 Million | 2.83 Million | 2.83 Million | -4.89 Million |
OPESF
002173
GJST
CONCORD
VBSN
JUBILE